Meet the authors
Hannah Abrams, MD (she/her) is a fellow in Hematology/Oncology at Fred Hutchinson Cancer Center and the University of Washington. She is originally from Houston, Texas, and completed her MD at Baylor College of Medicine before completing Internal Medicine residency at Massachusetts General Hospital.
Ivy Riano, MD (she/her) is the Research Chief Fellow in the Hematology and Oncology Fellowship program at Dartmouth Cancer Center. Dr. Riano’s research interests include the development of novel immunotherapeutic combinations for patients with lung cancer, and the application of approaches to
overcome resistance to immunotherapy.
Abdul Moiz Khan, MD (he/his) is the Chief Fellow of the Hematology and Oncology fellowship program at Karmanos Cancer Institute / Wayne State University. His areas of interest include malignant and classical hematology, with a strong focus on myeloid malignancies and medical education.
Inas Abuali, MD, FACP (she/her) is a physician at the Massachusetts General Hospital Cancer Center and Instructor of Medicine at Harvard Medical School. She specializes in the care of hospitalized patients. She is a member of the BTF Education Academy.
